Revvity to acquire ACD/Labs to expand software capabilities Nov 10, 2025 07:45AM
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities Nov 10, 2025 07:45AM
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing Jan 13, 2025 08:00AM
Revvity Announces Financial Results for the Second Quarter of 2023 Aug 1, 2023 06:00AM
Revvity Board Declares Quarterly Dividend Jul 21, 2023 04:05PM


Jul 20, 2023 08:00AM Revvity Accelerates NGS Library Prep with Introduction of New Fontus Automated Liquid Handling Workstation at 2023 AACC
Jul 12, 2023 08:00AM Revvity to Hold Earnings Call on Tuesday, August 1, 2023
Jun 29, 2023 08:00AM Honeycomb Biotechnologies and Revvity Launch New Solutions to Expand the Frontiers of Single Cell Research
Jun 12, 2023 08:00AM Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development
Jun 1, 2023 09:00AM Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with New Automated IIFT System
May 24, 2023 08:00AM Revvity to Present at Goldman Sachs Global Healthcare Conference
May 18, 2023 06:00AM Revvity Announces New License Agreement for Next-Generation Base Editing Technology